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Seungju Lee1, Jeeyeon Lee2, Seokwon Lee2 and Youngtae Bae2*Abstract
Background: The latissimus dorsi myocutaneous flap (LDMCF) is frequently applied to breast cancer patients for
breast reconstruction. However, the LDMCF is considered inappropriate for patients with ptotic breast. The authors
investigated combining LDMCF and two local flaps for large defects of the breast after partial mastectomy in
patients with ptosis.
Methods: Nineteen patients with breast cancer underwent a partial mastectomy with immediate reconstruction.
Reconstruction methods consisted of LDMCF, thoraco-epigastric flap, and inferior pedicled rotational local flap,
referred to as a combined pedicle flap. The cosmetic results were self-assessed after chemotherapy and radiotherapy
by a four-point scoring system.
Results: Ptosis was graded as follows: two patients with grade 1, 10 patients with grade 2, and seven patients with
grade 3. The mean tumor size was 2.7 cm and multifocality was identified in 11 patients (57.9%). The mean excised
volume was 468.5 cm3 and the percentage of excised volume was 46.2%. The cosmetic results were excellent in five
patients, good in seven patients, fair in six patients, and poor in one patient.
Conclusion: The combined pedicle flap, consisting of LDMCF, thoraco-epigastric flap, and inferior pedicled rotational
local flap, allows good cosmesis in breast cancer patients with large breasts or ptosis despite a wide excision.
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The latissimus dorsi myocutaneous flap (LDMCF) is a
useful method as oncoplastic breast surgery. LDMCF
can supply adequate volume and be easily acquired. Be-
sides, it has an advantage of low complication rates.
LDMCF is, however, considered inappropriate for pa-
tients with ptotic breast. Though the saline-filled pros-
thesis is combined with LDMCF, the natural shape of
drooping breast cannot be achieved. Therefore, bilateral
reduction mammoplasty is widely used for breast cancer
patients with large or ptotic breast [1-5]. The location of
the tumor, however, is the limiting factor of reduction* Correspondence: bytae@pusan.ac.kr
2Department of Surgery, Medical Research Institute, Pusan National
University, Ami-dong 1-ga, Seo-gu, Busan 602-739, Republic of Korea
Full list of author information is available at the end of the article
© 2014 Lee et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormammoplasty. In addition, reduction mammoplasty alone
cannot satisfy the cosmetic result for large defects. Is it,
then, impossible to apply LDMCF to the breast can-
cer patients with ptotic breasts? We combined LDMCF,
thoraco-epigastric flap (TEF), and inferior pedicled rota-
tional local flap (IPRLF), as a ‘combined pedicle flap,’ for
large defects in women with macromastia or ptotic
breast.Methods
From July 2010 to November 2011, we performed partial
mastectomy with a combination of LDMCF, TEF, and
rotational local flap on 19 patients with ptotic breast.
Ptosis was graded according to the Regnault classifica-
tion (Table 1) [6]. Magnetic resonance imaging (MRI) of
breast was performed in all patients, and the preoperative. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Regnault’s classification of ptosis
Minor ptosis (1st degree) Nipple at inframammary fold
Moderate ptosis (2nd degree) Nipple below inframammary fold,
but above lower breast contour
Severe ptosis (3rd degree) Nipple below inframammary fold,
and at lower breast contour
Glandular ptosis Nipple above inframammary fold,
but breast hangs below fold
Pseudoptosis Nipple above inframammary fold,
but breast is hypoplastic and hangs
below fold
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stitution of MRI. The excised breast volume was calcu-
lated using the records of pathologic reports.
Indications for this combined pedicle flap were pa-
tients with ptotic breasts who refused bilateral reduction
mammoplasty because of the scar on the contralateral
breast. A combined pedicle flap was also planned when
patients had more than 2 cm of breast cancer or less
than 2 cm with multifocal breast cancer. In these cases,
an immediate additional combination of flap was per-
formed when the surgical margin was positive and fur-
ther excision was required or the tumor size was larger
than the preoperative evaluation or the defect could not
be filled with LDMCF only.
Patients who had scars on the back, or previous sur-
gery in the axilla region were excluded in this study. Pa-
tients were asked to rate their cosmetic results using a
scale of 1 to 4 after chemotherapy and radiotherapy.
This study was retrospectively reviewed and approved
by the Institutional Review Board, and all patients pro-
vided written informed consent.
Surgical technique
First, we must obtain LDMCF to replace the defect of
the breast. In a lateral supine position, the donor site
skin incision was elliptical, ranged from 5 to 7 cm wide
and from 15 to 18 cm long. The obtained LDMCF was
put in a subcutaneous pocket in the posterior axillary
fold. The skin flap was fixed using monosyn 3-0 sutures
4 cm apart started at the base of the upper flap and at
the inferior limit of the LD resection in relation to the
iliac crest.
The patient was then placed in a supine position with
both arms abducted. The line of the IPRLF was incised
from the mid-axillary line to the tumor location, follow-
ing the skin crease (Figure 1A). Through this incision, a
sentinel lymph node biopsy was done if needed and the
tumor was resected with 1-2 cm of the margin to ensure
oncologic safety (Figure 1A). A circumferential intra-
operative frozen biopsy was done on the remnant breast
tissue, and additional breast tissue was resected when
the frozen biopsy results were positive. The posterioraxillary line was then dissected and the LDMCF was
passed under the tunnel. The island skin of LDMCF was
de-epithelialized thinly, and the LDMCF was inserted
into the place where the breast tissue was removed.
The TEF was designed with a width greater than 8 cm
(Figure 1A). The TEF should be obtained with skin, sub-
cutaneous fat, and the anterior serratus muscle fascia. The
superior epigastric vessels and perforators must be pre-
served because these are the vascular supply of this flap.
The skin of TEF was de-epithelialized, and the prepared
TEF was transposed under a tunnel of breast parenchyma
from the inframammary fold to the lower outer region of
breast defect (Figure 1B). Large defects from partial mast-
ectomies would be completely filled with LDMCF and
TEFs. The counter traction of IPRLF was done and the
‘dog ear’ was removed on the both sides of the inci-
sion (Figure 1C). After placing a drain in the defect,
the wounds were closed, using 3-0 and 4-0 absorbable
monofilament sutures. The drain was removed when
the volume drained was less than 50 cc.
Results
The mean age of the 19 patients was 49.6 years (range,
32 to 69 years). Two patients had grade 1 ptosis, 10
patients had grade 2 ptosis, and seven patients had grade
3 ptosis. The mean initial tumor size on preoperative
evaluation was 2.4 cm (range, 1.1 to 5.0 cm), and the
mean pathologic tumor size was 2.7 cm (range, 0.8 to
8.0 cm). The location of the tumor was as follows: upper
outer quadrant (n = 7); upper central area (n = 3); lower
outer quadrant (n = 4); lateral area (n = 2); medial area
(n = 1); central area (n = 1); and upper inner quadrant
(n = 1). Eleven cases had multifocal breast cancer. The
mean excised breast volume was 468.5 cm3 (range, 105.0
to 1,734.0 cm3) and the mean percentage of excised breast
volume was 46.2% (range, 19.6 to 97.3%). The mean dur-
ation of surgery was 269.3 min (range, 135.0 to 345.0),
and the mean hospital stay was 12.4 days (range, 7 to
27 days). Patients’ pathologic stages were as follows: ductal
carcinoma in situ (n = 1); I (n = 1); IIA (n = 7); IIB (n = 7);
IIIA (n = 1); and IIIC (n = 2). Wound dehiscence occurred
in two cases. These complications resulted from poor
vascular supply at the TEF donor site (Table 2). These
were resolved with conservative management and wound
revision.
Cosmetic outcomes were self-reported to be excellent
in five cases (26.3%), good in seven cases (36.8%), fair in
six cases (31.6%), and poor in one case (5.3%; Table 3).
Discussion
The application of oncoplastic surgery depends on the tu-
mor size, tumor location, ratio of tumor to whole breast
volume, and range of excision volume [7-12]. There are,
therefore, a number of possible oncoplastic techniques for
Figure 1 Combined pedicle flap surgical technique. (A) Through an incision (1), the partial mastectomy was done (2). The width of TEF (3)
should be more than 8 cm. (B) The obtained TEF placed at the lower outer border of LDMCF (3’). Defect from partial mastectomies would be
filled with LD flap (4) and TEF. (C) The counter traction (5) of the inferior pedicled rotational local flap was done and the ‘dog ear’ (6) was
trimmed off both sides of the incision. (D) Completion of the combined pedicle flap.
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fects caused by resection of breast tissue. Generally, the
LDMCF is best suited for small or moderate sized breasts
[13-17]. However, LDMCF will require additional tech-
nique, such as mastopexy or reduction mammoplasty, in
the contralateral breast to obtain symmetry, when it is
used for patients with large or ptotic breasts. Although
the LDMCF is best suited for cases where tumors are sit-
uated in the upper, central, or lateral quadrants of the
breast, in our study of nine patients, the tumor was lo-
cated in the outer quadrant area and another six were in
the upper inner quadrant area. For evaluation of possibil-
ity of immediate postoperative asymmetry and volume dif-
ference between both breasts during surgery, we have
performed temporary skin closure after partial mastec-
tomy defect replaced with LDMCF. The possibility will be
increased in lean patients with thin LDMCF. In case
there is a possibility of this and further deterioration
in long-term follow-up after radiotherapy including fi-
brosis and becoming smaller than contralateral breast,we have planned combined flaps in these cases, instead of
only LDMCF.
In addition, it is difficult to predict the volume of
LDMCF; we occasionally encounter some cases in which
LDMCF is insufficient for large defects. The combina-
tion of LDMCF and implants could fill a large defect.
There is, however, a high risk of complications, such as
capsular fibrosis and contracture of the adjacent tissue,
in the late course after reconstruction with the LDMCF
in combination with a prosthesis [18-20]. When the im-
plant cannot be fixed in the appropriate place, the cos-
metic result will be poor. Patients would feel a foreign
body sensation if a prosthesis implant is used instead of
the autologous tissue.
Reduction mammoplasty can be useful in patients with
macromastia or ptosis. But the location of the tumor is
the limiting factor of reduction mammoplasty. When
the tumor is located in the upper inner quadrant, reduc-
tion mammoplasty cannot be an appropriate method
[2,3]. Reduction mammoplasty is also limited to tumor
Table 2 Characteristics of the 19 patients who underwent combined pedicle flap procedure










1 3 60 2.5 Upper central 381.9 42.7 IIA Fair
2 3 46 3.2 Medial 378.6 27.6 IIB Fair
3 3 69 1.3 Upper outer 261.9 22.4 IIA Excellent
4 2 53 8.0 Upper outer 972.0 61.1 DCIS Excellent
5 2 38 2.0 Upper outer 160.7 21.6 IIA Good
6 1 43 2.5 Lower outer 345.0 53.9 IIB Excellent
7 2 51 1.6 Upper outer 465.0 36.0 IIA Good
8 3 37 4.0 Upper inner 1,734.0 97.3 IIB Poor
9 2 50 2.1 Upper central 1,080.3 67.5 IIB Fair
10 2 59 3.1 Lower outer 324.0 32.0 IIIA Good
11 2 58 2.4 Lateral 341.0 53.0 IIB Good
12 1 32 2.2 Upper outer 180.0 54.8 IIB Excellent
13 3 38 2.5 Lower outer 330.0 46.3 IIB Fair
14 2 48 0.8 Upper central 198.0 73.3 I Fair
15 3 53 3.2 Lateral 815.2 87.2 IIIC Good
16 2 45 3.7 Lower outer 105.0 21.4 IIA Fair
17 2 52 2.5 Central 450.0 36.7 IIA Good
18 3 52 2.2 Upper outer 178.0 22.5 IIIC Good
19 2 58 2.2 Upper outer 201.3 19.6 IIA Excellent
Mean 49.6 2.7 468.5 46.2
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icle, which could lead to a poor cosmetic result, is ap-
plied to the tumor in that area [1,4,5]. Besides, the scar
of the other breast might be annoying to the patients.
Our technique, which consists of LDMCF, TEF, and
IPRLF, had no limitation of tumor location and could
obtain good cosmetic results despite of wide excision.
As shown in Figure 2, patient 17 had been diagnosed
with breast cancer in the central region. She had mul-
tiple daughter cells in the upper inner site around the
main tumor mass. We had to resect more breast tissue
to obtain oncologic safety; therefore, we tried combined
pedicle flaps in this patient. Her tumor stage was IIA
and the percentage of excised breast volume was identi-
fied as 36.7%. As shown in Table 2, the cosmetic result
of this case was good. And we had six more patientsTable 3 Cosmetic outcomes of the 19 patients who
underwent combined pedicle flap surgery




Poor 1 (5.3)with positive margin during the operation, and their cos-
metic results were also good.
Generally, excision of more than 20% of breast volume
predicts poor cosmetic result [21,22]. In our study, the
mean percentage of excised volume was 46.2%; there-
fore, this is a remarkable result with which to obtain
oncologic safety. When the cancer or atypical ductal
hyperplasia was identified in the intraoperative frozen
section, the breast tissue excision was larger than the
presumed volume. The combination of LDMCF, TEF,
and rotational local flap would resolve this problem.
In ptotic breast patients, the upper chest region is flat
and the glandular portion is drooping around the infra-
mammary line. IPRLF could reduce the requirement of
volume in the upper chest region, and fix the LDMCF
from medial to lower region of the breast defect. When
the LDMCF is passed through the tunnel, beneath the
skin bridge separating the mastectomy and donor site, the
mid axillary region may be bulging with this LD flap. This
bulging of LDMCF could cause discomfort to patients
after surgery. The IPRLF could help LDMCF transpose to
the appropriate position without bulging because the
counter traction of IPRLF can remove the tunnel space
(Figure 1C). The Nipple-areolar complex (NAC) is often
deviated upward when the LDMCF is only used in the
volume replacement. To prevent this, we modified the
Figure 2 Patient with multifocality. (A) Preoperative view with marking of the skin incision. (B) Defect (dot circle) by transillumination after
partial mastectomy. (C) Skin incision marking for TEF. The width of TEF should be more than 8 cm. (D) TEF would be rotated to lower outer
margin of LDMCF. (E) Combination of LDMCF and TEF is filling the defect. (F) Skin closure after combined pedicle flap.
Figure 3 Outcomes of combined pedicle flap. (A, C, E) Preoperative views marked with breast cancer locations (dot circle). (B, D, F) Postoperative
views after radiotherapy.
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ward [23]. The angle of rotation of TEF was obtuse
to place the TEF at the lower outer border of LDMCF
(Figure 1B). This combined pedicle flap, therefore, could
achieve natural shape of the breast in ptotic breast pa-
tients. In our study, cosmetic outcomes were evaluated at
least 6 months postoperatively. Although the number of
this study was small, cosmetic results were generally ac-
ceptable, as shown in Figure 3.
As we mentioned in our previous study [23], the infer-
ior scar of TEF is not visible on the front view and it
creates a neo-inframammary line (Figure 1D). This is an
advantage of this procedure compared to the scar of the
contralateral breast in the reduction mammoplasty.
Although the mean operative time was 269.3 minutes,
it can be shortened with surgical experience.
In our experience, some complications occurred, such
as wound dehiscence caused by fat necrosis. In the case
of wound dehiscence, it resulted in a relatively long
hospital stay and poor cosmetic result. To prevent this
complication, we designed the width of TEF as over than
8 cm and obtained TEF meticulously, using a Mayo scis-
sor (Figure 1A). The use of Mayo scissor could avoid the
thermal injury of electrocautery on the vascular supply of
this flap.
Conclusion
Combination of TEF and IPRLF could reduce the re-
quirement of volume when LDMCF is insufficient for
the large defects in patients, especially reluctant to the
scar of the contralateral breast. The combined pedicle
flap allows oncologic safety and good cosmetic results in
breast cancer patients with large breasts or ptosis, des-
pite a wide excision.
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